Gilead Sciences (GILD) FCF Margin (2009 - 2026)

Gilead Sciences (GILD) has reported FCF Margin for 18 consecutive years, with 34.87% the latest figure, recorded in Q1 2026.

• FCF Margin for Q1 2026 came in at 34.87%, up 1008.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 34.4% (up 14.0% YoY), and the FY2025 annual result was 32.12%, down 372.0% from the prior year.
• FCF Margin was 34.87% for Q1 2026 at Gilead Sciences, down from 39.39% in the prior quarter.
• Over five years, FCF Margin peaked at 55.24% in Q3 2024 and troughed at 10.17% in Q2 2025.
• Average FCF Margin over 5 years is 31.34%, with a median of 31.62% recorded in 2024.
• The widest YoY moves for FCF Margin: up 3208 bps in 2024, down 1614 bps in 2024.
• Over 5 years, FCF Margin stood at 32.29% in 2022, then retreated by 15 bps to 27.47% in 2023, then surged by 36 bps to 37.36% in 2024, then increased by 5 bps to 39.39% in 2025, then declined by 11 bps to 34.87% in 2026.
• Per Business Quant data, the three most recent FCF Margin figures were 34.87% in Q1 2026, 39.39% in Q4 2025, and 50.98% in Q3 2025.